Source: centralcharts

Press Release: ReNetx : ReNetX Bio Receives Fast Track Designation From U.S. FDA

NEW HAVEN, Conn., Jan. 08, 2020 (GLOBE NEWSWIRE) -- ReNetX Bio announced today that the U.S. Food and Drug Administration (FDA) has granted the company Fast...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Erika R. Smith's photo - CEO of ReNetx

CEO

Erika R. Smith

CEO Approval Rating

75/100

Read more